Tickerplace logo

Tickerplace

Krystal Biotech, Inc. logo

KRYSKrystal Biotech, Inc.

KRYS Stock Price, Valuation & Chart | Krystal Biotech, Inc.

Compare
$316.58-13.42 (-4.07%)

At close · 16 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Biotechnology
OverviewFinancialsDividendsRatios

KRYS Historical price chart

KRYS Key Stats

Market Capitalization9.37B
PE Ratio39.67
EPS7.98
Trading Volume226.22K
Today's High/Low331.04/315.02
Dividend Yield0.00
52 Week High/Low382.54/183.03
Shares Outstanding29.60M
KRYS Financial Statement
KRYS Analyst ratings
KRYS Analysis & performance metrics

KRYS Company profile

Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead…

KRYS Management team

Management
Josh SuskinCTO
Senior Director & Head of US Human Resources
Laurent Goux
Senior Vice President & GM of Europe
John Thomas
General Counsel & Corporate Secretary
Suma M. KrishnanCTO
Founder, President of R&D and Director
Stephane Paquette Ph.D.
Vice President of Corporate Development
David Chien M.D.
Senior Vice President of Clinical Development
Christine Wilson
Head of U.S. Sales & Marketing
Kathryn A. Romano CPA
Executive Vice President & Chief Accounting Officer
Total 8 executives

KRYS Frequently asked questions

What is Krystal Biotech, Inc. (KRYS) Stock Price?

Current stock price of Krystal Biotech, Inc. (KRYS) stock is $316.58. The stock price is -4.07% lower in the session. The intraday range can be seen from this page. Volume of Krystal Biotech, Inc. (KRYS) stock is 226.22K.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Krystal Biotech, Inc. (KRYS) stock price going up or down today?

The stock price of Krystal Biotech, Inc. (KRYS) can change with earnings, company news, and overall market sentiment. Krystal Biotech, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Krystal Biotech, Inc. stock expensive at its current price?

Whether Krystal Biotech, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for KRYS on this page is 39.67. EPS on this page is 7.98. Compare those figures with peers and growth expectations before deciding if the current Krystal Biotech, Inc. price is justified.

How has the stock price of Krystal Biotech, Inc. (KRYS) performed historically?

Historical performance for Krystal Biotech, Inc. (KRYS) is shown on the price chart on this page. Review multi-period moves alongside volume to see how KRYS reacted to past earnings and market events.

Should I buy Krystal Biotech, Inc. (KRYS) stock, at this price?

Buying Krystal Biotech, Inc. (KRYS) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.